Indapamid Krka

Indapamide, the active ingredient in Indapamid Krka, is a thiazide‑like diuretic presented as an oral dosage form for oral use. It is used to treat hypertension and to reduce edema associated with heart failure in adult patients.\n\nGNH India supplies Indapamid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide acts on the renal distal convoluted tubule and vascular resistance pathways to manage fluid balance and blood pressure.\n\nHypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension.\nEdema associated with heart failure: promotes diuresis to reduce fluid overload and peripheral swelling.\nCongestive heart failure: assists in controlling volume status and improving symptom relief.

Indapamide may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Dizziness or light‑headedness\n- Headache\n- Increased frequency of urination\n- Electrolyte disturbances, especially low potassium\n- Muscle cramps or weakness\n- Fatigue\n\nSerious or Rare Side Effects:\n- Severe dehydration or electrolyte imbalance\n- Hyponatremia or hyperuricemia leading to gout attacks\n- Allergic reactions such as rash, angioedema, or anaphylaxis\n- Pancreatitis\n- Blood dyscrasias including leukopenia or thrombocytopenia

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.\n\nMonitor electrolytes: check serum potassium and sodium regularly.\nAssess renal function: evaluate creatinine clearance before and during treatment.\nUse caution in diabetes: may affect glucose control.\nAvoid in severe hepatic impairment: limited data on safety.\nEvaluate gout risk: hyperuricemia may precipitate attacks.\nStore at room temperature: keep in the original container, protect from moisture and direct sunlight.

Indapamide can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.\n\nMajor Interactions (Avoid):\n- Lithium: risk of lithium toxicity due to reduced clearance.\n- Ciclosporin: increased nephrotoxic potential.\n- Antidiabetic agents: may enhance hypoglycaemic effect.\n\nModerate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: may potentiate hypotensive effect.\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs): may diminish diuretic response and affect renal function.\n- Other antihypertensives: additive blood‑pressure lowering may require dose adjustment.